Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Zhang GP, Xie ZL, Jiang J, Zhao YT, Lei K, Lin ZL, Chen SL, Su TH, Tan L, Peng S, Wang J, Liu C, Kuang M. Mechanical confinement promotes heat resistance of hepatocellular carcinoma via SP1/IL4I1/AHR axis. Cell Rep Med 2023;4:101128. [PMID: 37478857 PMCID: PMC10439175 DOI: 10.1016/j.xcrm.2023.101128] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2022] [Revised: 03/10/2023] [Accepted: 06/23/2023] [Indexed: 07/23/2023]

Number

Cited by Other Article(s)

Zhou Z, Song P, Wu Y, Wang M, Shen C, Ma Z, Ren X, Wang X, Chen X, Hu Y, Li Z, Zhang Q, Li M, Geng Z, Su J. Dual-network DNA-silk fibroin hydrogels with controllable surface rigidity for regulating chondrogenic differentiation. Mater Horiz 2024;11:1465-1483. [PMID: 38221872 DOI: 10.1039/d3mh01581e] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/16/2024]

Abstract

Osteoarthritis (OA) is a common joint disease known for cartilage degeneration, leading to a substantial burden on individuals and society due to its high disability rate. However, current clinical treatments for cartilage defects remain unsatisfactory due to the unclear mechanisms underlying cartilage regeneration. Tissue engineering hydrogels have emerged as an attractive approach in cartilage repair. Recent research studies have indicated that stem cells can sense the mechanical strength of hydrogels, thereby regulating their differentiation fate. In this study, we present the groundbreaking construction of dual-network DNA-silk fibroin (SF) hydrogels with controllable surface rigidity. The supramolecular networks, formed through DNA base-pairing, induce the development of β-sheet structures by constraining and aggregating SF molecules. Subsequently, SF was cross-linked via horseradish peroxidase (HRP)-mediated enzyme reactions to form the second network. Experimental results demonstrated a positive correlation between the surface rigidity of dual-network DNA-SF hydrogels and the DNA content. Interestingly, it was observed that dual-network DNA-SF hydrogels with moderate surface rigidity exhibited the highest effectiveness in facilitating the migration of bone marrow mesenchymal stem cells (BMSCs) and their chondrogenic differentiation. Transcriptome sequencing further confirmed that dual-network DNA-SF hydrogels primarily enhanced chondrogenic differentiation of BMSCs by upregulating the Wnt and TGF-β signaling pathways while accelerating collagen II synthesis. Furthermore, in vivo studies revealed that dual-network DNA-SF hydrogels with moderate surface rigidity significantly accelerated cartilage regeneration. In summary, the dual-network DNA-SF hydrogels represent a promising and novel therapeutic strategy for cartilage regeneration.

Collapse

Affiliation(s)

Ziyang Zhou Institute of Translational Medicine, Shanghai University, Shanghai, 200444, China. Organoid Research Center, Shanghai University, Shanghai, 200444, China National Center for Translational Medicine (Shanghai) SHU Branch, Shanghai University, Shanghai, 200444, China School of Medicine, Shanghai University, Shanghai, 200444, China School of Life Sciences, Shanghai University, Shanghai, 200444, China
Peiran Song Institute of Translational Medicine, Shanghai University, Shanghai, 200444, China. Organoid Research Center, Shanghai University, Shanghai, 200444, China National Center for Translational Medicine (Shanghai) SHU Branch, Shanghai University, Shanghai, 200444, China
Yan Wu Institute of Translational Medicine, Shanghai University, Shanghai, 200444, China. Organoid Research Center, Shanghai University, Shanghai, 200444, China National Center for Translational Medicine (Shanghai) SHU Branch, Shanghai University, Shanghai, 200444, China
Miaomiao Wang Institute of Translational Medicine, Shanghai University, Shanghai, 200444, China. Organoid Research Center, Shanghai University, Shanghai, 200444, China National Center for Translational Medicine (Shanghai) SHU Branch, Shanghai University, Shanghai, 200444, China
Congyi Shen Institute of Translational Medicine, Shanghai University, Shanghai, 200444, China. Organoid Research Center, Shanghai University, Shanghai, 200444, China National Center for Translational Medicine (Shanghai) SHU Branch, Shanghai University, Shanghai, 200444, China School of Medicine, Shanghai University, Shanghai, 200444, China School of Life Sciences, Shanghai University, Shanghai, 200444, China
Zhixin Ma Institute of Translational Medicine, Shanghai University, Shanghai, 200444, China. Organoid Research Center, Shanghai University, Shanghai, 200444, China National Center for Translational Medicine (Shanghai) SHU Branch, Shanghai University, Shanghai, 200444, China School of Medicine, Shanghai University, Shanghai, 200444, China School of Life Sciences, Shanghai University, Shanghai, 200444, China
Xiaoxiang Ren Institute of Translational Medicine, Shanghai University, Shanghai, 200444, China. Organoid Research Center, Shanghai University, Shanghai, 200444, China National Center for Translational Medicine (Shanghai) SHU Branch, Shanghai University, Shanghai, 200444, China
Xiuhui Wang Institute of Translational Medicine, Shanghai University, Shanghai, 200444, China. Organoid Research Center, Shanghai University, Shanghai, 200444, China National Center for Translational Medicine (Shanghai) SHU Branch, Shanghai University, Shanghai, 200444, China
Xiao Chen Department of Orthopedics, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, China
Yan Hu Department of Orthopedics, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, China
Zuhao Li Institute of Translational Medicine, Shanghai University, Shanghai, 200444, China. Organoid Research Center, Shanghai University, Shanghai, 200444, China National Center for Translational Medicine (Shanghai) SHU Branch, Shanghai University, Shanghai, 200444, China Department of Orthopedics, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, China
Qin Zhang Institute of Translational Medicine, Shanghai University, Shanghai, 200444, China. Organoid Research Center, Shanghai University, Shanghai, 200444, China National Center for Translational Medicine (Shanghai) SHU Branch, Shanghai University, Shanghai, 200444, China
Mengmeng Li Institute of Translational Medicine, Shanghai University, Shanghai, 200444, China. Organoid Research Center, Shanghai University, Shanghai, 200444, China National Center for Translational Medicine (Shanghai) SHU Branch, Shanghai University, Shanghai, 200444, China
Zhen Geng Institute of Translational Medicine, Shanghai University, Shanghai, 200444, China. Organoid Research Center, Shanghai University, Shanghai, 200444, China National Center for Translational Medicine (Shanghai) SHU Branch, Shanghai University, Shanghai, 200444, China
Jiacan Su Institute of Translational Medicine, Shanghai University, Shanghai, 200444, China. Organoid Research Center, Shanghai University, Shanghai, 200444, China National Center for Translational Medicine (Shanghai) SHU Branch, Shanghai University, Shanghai, 200444, China Department of Orthopedics, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, China

Collapse

Ye F, Wang L, Li Y, Dong C, Zhou L, Xu J. IL4I1 in M2-like macrophage promotes glioma progression and is a promising target for immunotherapy. Front Immunol 2024;14:1338244. [PMID: 38250074 PMCID: PMC10799346 DOI: 10.3389/fimmu.2023.1338244] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2023] [Accepted: 12/12/2023] [Indexed: 01/23/2024] Open

Abstract

Background

Glioma is the prevailing malignant intracranial tumor, characterized by an abundance of macrophages. Specifically, the infiltrating macrophages often display the M2 subtype and are known as tumor-associated macrophages (TAMs). They have a critical role in promoting the oncogenic properties of tumor cells. Interleukin-4-induced-1 (IL4I1) functions as an L-phenylalanine oxidase, playing a key part in regulating immune responses and the progression of various tumors. However, there is limited understanding of the IL4I1-mediated cross-talk function between TAMs and glioma cell in the glioma microenvironment.

Methods

TCGA, GTEx, and HPA databases were applied to assess the IL4I1 expression, clinical characteristics, and prognostic value of pan-cancer. The link between IL4I1 levels and the prognosis, methylation, and immune checkpoints (ICs) in gliomas were explored through Kaplan-Meier curve, Cox regression, and Spearman correlation analyses. The IL4I1 levels and their distribution were investigated by single-cell analysis and the TIMER 2 database. Additionally, validation of IL4I1 expression was performed by WB, RT-qPCR, IHC, and IF. Co-culture models between glioma cells and M2-like macrophages were used to explore the IL4I1-mediated effects on tumor growth, invasion, and migration of glioma cells. Moreover, the function of IL4I1 on macrophage polarization was evaluated by ELISA, RT-qPCR, WB, and siRNA transfection.

Results

Both transcriptome and protein levels of IL4I1 were increased obviously in various tumor types, and correlated with a dismal prognosis. Specifically, IL4I1 was implicated in aggressive progression and a dismal prognosis for patients with glioma. A negative association was noticed between the glioma grade and DNA promoter methylation of IL4I1. Enrichment analyses in glioma patients suggested that IL4I1 was linked to cytokine and immune responses, and was positively correlated with ICs. Single-cell analysis, molecular experiments, and in vitro assays showed that IL4I1 was significantly expressed in TAMs. Importantly, co-culture models proved that IL4I1 significantly promoted the invasion and migration of glioma cells, and induced the polarization of M2-like macrophages.

Conclusion

IL4I1 could be a promising immunotherapy target for selective modulation of TAMs and stands as a novel macrophage-related prognostic biomarker in glioma.

Collapse